These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9304221)

  • 1. [Quality of the Early Cervical Cancer Detection Program in the State of Nuevo León].
    Salinas-Martínez AM; Villarreal-Ríos E; Garza-Elizondo ME; Fraire-Gloria JM; López-Franco JJ; Barboza-Quintana O
    Salud Publica Mex; 1997; 39(3):187-94. PubMed ID: 9304221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the Pap test by a population group in Buenos Aires.
    Klimovsky E; Matos E
    Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities.
    Mintzer M; Curtis P; Resnick JC; Morrell D
    Cancer; 1999 Jun; 87(3):113-7. PubMed ID: 10385441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with non-use of Pap test. A population survey.
    Hernández-Hernández DM; García-Elizondo MR; Ornelas-Bernál L; Hernández-Alemán F; González-Lira G; Martínez-García MC
    Arch Med Res; 1998; 29(3):263-70. PubMed ID: 9775462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality differences between rural and urban primary care: the case of a cervical cancer screening programme.
    Salinas AM; Villarreal E; Garza ME; Fraire JM; Lopez JJ; Nuñez GM
    Int J Qual Health Care; 1998 Jun; 10(3):235-40. PubMed ID: 9661062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why women still die from cervical cancer.
    Masood S
    J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational level and cervical cancer screening programs in a Venezuelan urban area.
    Núñez-Troconis J; Velásquez J; Mindiola R; Munroe D
    Invest Clin; 2008 Sep; 49(3):331-9. PubMed ID: 18846774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
    Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
    Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
    Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.